Group One Trading’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-29,231
| Closed | -$519K | – | 5809 |
|
|
2018
Q3 | $519K | Sell |
29,231
-35,357
| -55% | -$607K | ﹤0.01% | 2247 |
|
|
2018
Q2 | $891K | Buy |
+64,588
| New | +$767K | 0.01% | 1833 |
|
|
2018
Q1 | – | Sell |
-13,578
| Closed | -$74.9K | – | 5623 |
|
|
2017
Q4 | $58K | Sell |
13,578
-3,342
| -20% | -$15.9K | ﹤0.01% | 3655 |
|
|
2017
Q3 | $24K | Buy |
16,920
+1,100
| +7% | +$1.53K | ﹤0.01% | 3995 |
|
|
2017
Q2 | $24K | Buy |
+15,820
| New | +$34K | ﹤0.01% | 3879 |
|
|
2016
Q2 | – | Sell |
-1,597
| Closed | -$5.85K | – | 5148 |
|
|
2016
Q1 | $5K | Buy |
+1,597
| New | +$5.21K | ﹤0.01% | 4222 |
|
|
2015
Q3 | – | Sell |
-13,427
| Closed | -$70.3K | – | 5435 |
|
|
2015
Q2 | $70K | Buy |
+13,427
| New | +$80.5K | ﹤0.01% | 3334 |
|
|
2015
Q1 | – | Sell |
-35,138
| Closed | -$203K | – | 5443 |
|
|
2014
Q4 | $221K | Sell |
35,138
-30,349
| -46% | -$185K | ﹤0.01% | 2235 |
|
|
2014
Q3 | $398K | Buy |
+65,487
| New | +$447K | 0.01% | 1794 |
|
|
2013
Q4 | – | Sell |
-14,389
| Closed | -$159K | – | 5706 |
|
|
2013
Q3 | $192K | Buy |
14,389
+12,574
| +693% | +$199K | ﹤0.01% | 2419 |
|
|
2013
Q2 | $24K | Buy |
+1,815
| New | +$24.5K | ﹤0.01% | 3979 |
|
Other funds holding ECYT
Group One Trading's ECYT Position: Q4 2018 in Review
Group One Trading sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 29,231 shares — an estimated $519K sold.
Group One Trading first reported a position in ECYT in Q2 2013 and held it in 11 quarters. The position peaked at $891K in Q2 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.
- Group One Trading reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
- Group One Trading sold 29,231 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $519K.
- Group One Trading first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 11 quarters.
- Group One Trading's Endocyte, Inc. Common Stock position peaked at $891K in Q2 2018.
- 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.
Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.